Adolescents Treated For Obesity With GLP-1 Medications Are Less Likely To Have Suicidal Thoughts Or Attempts, Review Finds
CNN (10/15, Tirrell ) reports, “A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.” The study of roughly “7,000 children between ages 12 and 18…showed that the medicines were associated with a 33% lower risk over a year.” The findings were published in JAMA Pediatrics.
Related Links:
— “Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds,” Meg Tirrell, CNN, October 15, 2024